Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine [1]

Annals of Pharmacotherapy

Volumn 36, Issue 10, 2002, Pages 1647-1648

  Dougherty, John A ^a   Young, Harriet ^a   Shafi, Tariq ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; COTRIMOXAZOLE; CYCLOBENZAPRINE; DEXTROPROPOXYPHENE; DOCUSATE SODIUM; FLUCONAZOLE; GABAPENTIN; GENTAMICIN; LEVOFLOXACIN; LORAZEPAM; OXYBUTYNIN; PARACETAMOL; PETHIDINE; PREDNISOLONE; SALBUTAMOL; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; VENLAFAXINE;

ADULT; AUTONOMIC NERVOUS SYSTEM; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITION; FEMALE; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LETTER; NEUROMUSCULAR SYSTEM; PRIORITY JOURNAL; SEROTONIN SYNDROME;

EID: 0036785295     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C091     Document Type: Letter

References (7)

1. Mills KC. Serotonin syndrome: a clinical update. Crit Care Clin 1997;13: 763-83.
2. Brown TM, Skop BP, Mareth TR. Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 1996;30:527-33.
3. Perry NK. Venlafaxine-induced serotonin syndrome with relapse following amitriptyline. Postgrad Med J 2000;76:254-6.
4. McDaniel WW. Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother 2001;35:870-3.
5. Blackman JT, Kivisto KT, Wang JS, Neuvonen PJ. Antifungals. In: Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, eds. Metabolic drug interactions. Philadelphia: Lippincott Williams & Wilkins, 2000:623-46.
6. Robinson RF, Nahata MC, Olshefski RS. Syncope associated with concurrent amitriptyline and fluconazole therapy. Ann Pharmacother 2000; 34:1406-9.
7. Naranjo CA, Busto U, Sellers FM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.